For the Inventor, By the Inventor

Enter assignee name

Richmond, CA, United States of America

Lxr Biotechnology, Inc.

USPTO Granted Patents = 17

Forward Citations = 145

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Philip J Barr (13 out of 67 patents)

L David Tomei (11 out of 12 patents)

Ian C Bathurst (8 out of 14 patents)

4. John D Bradley (7 out of 37 patents)

5. Michael C Kiefer (5 out of 43 patents)

6. John P Shapiro (2 out of 2 patents)

7. Mauro Piacentini (1 out of 2 patents)

8. John G Goddard (1 out of 3 patents)

9. Matthew W Foehr (1 out of 6 patents)

10. Laszlo Fesus (1 out of 1 patent)

17 patents: Sort by Forward Citations

1. 6306398 - Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof (2001-10-23),

2. 6015687 - Apoptosis-modulating proteins, DNA encoding the proteins and methods of (2000-01-18),

3. 6004579 - Compositions which inhibit apoptosis, methods of making the compositions (1999-12-21),

4. 5998131 - Screening methods for the identification of compounds capable of (1999-12-07),

5. 5770443 - Apoptosis-modulating proteins, DNA encoding the proteins and methods of (1998-06-23),

6. 5759548 - Compositions which inhibit apoptosis, methods of purifying the (1998-06-02),

7. 5750360 - Method for quantitatively measuring apoptosis (1998-05-12),

8. 5681703 - Methods of identifying potentially therapeutically effective agents and (1997-10-28),

9. 5663070 - Recombinant production of a soluble splice variant of the Fas (Apo-1) (1997-09-02),

10. 5652210 - Soluble splice variant of the Fas (APO-1) antigen, Fas.DELTA.TM (1997-07-29),

11. 5637486 - Methods of identifying potentially therapeutically effective agents and (1997-06-10),

12. 5635187 - Compositions which inhibit apoptosis, methods of purifying the (1997-06-03),

13. 5635186 - Compositions which inhibit apoptosis, methods of purifying the (1997-06-03),

14. 5624672 - Compositions which inhibit apoptosis, methods of purifying the (1997-04-29),

15. 5620888 - Cell strains for use in identifying potentially therapeutically (1997-04-15),

Company Overview

Lxr Biotechnology, Inc. is a Richmond, California-based company focused on advancing therapeutic solutions through innovative biotechnology. The organization specializes in the development of novel treatments aimed at addressing unmet medical needs, leveraging cutting-edge research in areas such as drug discovery and molecular biology. With a commitment to scientific excellence, Lxr Biotechnology aims to contribute significantly to the healthcare landscape by translating complex biological insights into effective therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

17 Patents

#11 in Richmond, CA

#4,518 in California

#18,903 in US

#35,948 in the World

Richmond, CA, United States of America

Lxr Biotechnology, Inc.

Forward Citations = 145

10 inventors:

Philip J Barr (13 out of 67 patents)

L David Tomei (11 out of 12 patents)

Ian C Bathurst (8 out of 14 patents)

4. John D Bradley (7 out of 37 patents)

5. Michael C Kiefer (5 out of 43 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lxr Biotechnology, Inc.. Retrieved from https://idiyas.com/company/lxr-biotechnology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…